153 related articles for article (PubMed ID: 7758394)
1. Nationwide investigation in Japan on the efficacy of arbekacin in methicillin-resistant Staphylococcus aureus infections.
Hayashi I; Inoue M; Hashimoto H
Drugs Exp Clin Res; 1994; 20(6):225-32. PubMed ID: 7758394
[TBL] [Abstract][Full Text] [Related]
2. [Nationwide investigation in Japan of the status of MRSA infections and usefulness of arbekacin].
Hayashi I; Inoue M; Hashimoto H
Jpn J Antibiot; 1994 Jun; 47(6):595-605. PubMed ID: 8072167
[TBL] [Abstract][Full Text] [Related]
3. [Clinical efficacy of arbekacin in patients with methicillin-resistant Staphylococcus aureus infections. Research Group of MRSA Forum].
Nasuhara K; Takatsuka K; Takatsuka N; Teraoka M; Tokita S; Shinohara M; Azuma E; Saijo N; Sone H; Saito I
Jpn J Antibiot; 1994 Jun; 47(6):720-30. PubMed ID: 8072180
[TBL] [Abstract][Full Text] [Related]
4. [Treatment with arbekacin of surgical infections by resistant strains of Staphylococcus aureus. Arbekacin Study Group].
Morimoto K; Nakatani S; Kaji M; Kinoshita H; Fujimoto M; Hirata S; Ueda T; Tamate S; Yamazaki O
Jpn J Antibiot; 1994 Jun; 47(6):826-36. PubMed ID: 8072193
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy of arbekacin, a new aminoglycoside antibiotic, in surgical patients with MRSA infections].
Ishikawa S; Yura J; Shinagawa N; Mizuno A; Mashita K; Hori K
Jpn J Antibiot; 1994 Jun; 47(6):820-5. PubMed ID: 8072192
[TBL] [Abstract][Full Text] [Related]
6. [Clinical effect of the combined therapy of arbekacin and imipenem/cilastatin against methicillin-resistant Staphylococcus aureus].
Hashimoto A; Ohtsubo T; Tomono K; Kaku M; Koga H; Kohno S; Hara K; Sugiyama H; Taira K; Inoue Y
Jpn J Antibiot; 1994 Jun; 47(6):804-12. PubMed ID: 8072190
[TBL] [Abstract][Full Text] [Related]
7. [Clinical efficacy of arbekacin in deep MRSA infection. Including follow-up study after the termination of chemotherapy].
Kuwabara M; Konishi F; Yokoyama T; Kodama T; Santoh T; Nakai S; Miyoshi N; Kurimura T; Miyazawa T; Arita K
Jpn J Antibiot; 1994 Jun; 47(6):771-80. PubMed ID: 8072186
[TBL] [Abstract][Full Text] [Related]
8. [An evaluation study on arbekacin for MRSA-infectious diseases including pneumonia, septicemia and others].
Odagiri S; Sumitomo M; Takahashi K; Matsumoto F; Sakurai I; Imai T; Yoshikawa K; Ito A; Sugiyama M; Suzuki M
Jpn J Antibiot; 1994 Jun; 47(6):751-62. PubMed ID: 8072184
[TBL] [Abstract][Full Text] [Related]
9. [Clinical effect of arbekacin on MRSA infections after gastrointestinal surgery].
Ochiai M; Tanimura H; Noguchi K; Takifuji K; Konishi R; Ohkouchi N; Kouno N; Ohnishi H; Shimada K; Kasitani M
Jpn J Antibiot; 1994 Jun; 47(6):837-43. PubMed ID: 8072194
[TBL] [Abstract][Full Text] [Related]
10. [Clinical efficacy of arbekacin on MRSA infections].
Ichiyama S; Shimokata K
Jpn J Antibiot; 1994 Jun; 47(6):731-5. PubMed ID: 8072181
[TBL] [Abstract][Full Text] [Related]
11. [Questionnaires regarding MRSA in Japan].
Hayashi I; Inoue M; Hashimoto H
Jpn J Antibiot; 1994 Jun; 47(6):606-17. PubMed ID: 8072168
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of combination therapy against MRSA in Ibaraki Prefecture].
Otsuka M; Sawahata T; Nakai T; Hasegawa S; Iwata S; Yoshizawa Y; Ishida H; Irokawa M; Goto A; Shinohara Y
Jpn J Antibiot; 1994 Jun; 47(6):781-9. PubMed ID: 8072187
[TBL] [Abstract][Full Text] [Related]
13. [Staggered intensive chemotherapy using arbekacin, fosfomycin and ceftazidime on polymicrobial infections involving MRSA].
Tanaka T; Iida-Tanaka K; Takahara J; Fujioka Y; Tamura T; Yamanoi Y; Houjou S; Takahashi T; Miki S; Nakamura Y
Jpn J Antibiot; 1994 Jun; 47(6):790-7. PubMed ID: 8072188
[TBL] [Abstract][Full Text] [Related]
14. [Clinical efficacy of arbekacin on MRSA pneumonia].
Kawashima T; Shishibara T; Nakamura H; Kuriyama T; Kanno S; Watanabe M; Kikuchi N; Kunitomo F; Yamagishi F; Mizutani F
Jpn J Antibiot; 1994 Jun; 47(6):741-50. PubMed ID: 8072183
[TBL] [Abstract][Full Text] [Related]
15. [Clinical analysis of MRSA pneumonia. Niigata Research Group of MRSA.ABK].
Arakawa M; Wada K; Sega H; Yoshikawa H; Honma T; Miyao H; Shimazu Y; Tsukada H; Hoshino S; Sato S
Jpn J Antibiot; 1994 Jun; 47(6):736-40. PubMed ID: 8072182
[TBL] [Abstract][Full Text] [Related]
16. [Antimicrobial activities of arbekacin against methicillin-resistant Staphylococcus aureus].
Deguchi K; Suzuki Y; Ishihara R; Ishii Y; Nakazawa A; Matsumoto Y; Nishinari C; Nakane Y; Fukumoto T
Jpn J Antibiot; 1997 Jan; 50(1):1-11. PubMed ID: 9059909
[TBL] [Abstract][Full Text] [Related]
17. [Clinical studies on methicillin-resistant Staphylococcus aureus (MRSA) infections].
Okumura A; Muraishi Y; Tsuritani S; Sakamoto M; Kazama T; Fuse H; Katayama T
Hinyokika Kiyo; 1993 Dec; 39(12):1157-61. PubMed ID: 8285164
[TBL] [Abstract][Full Text] [Related]
18. [Vancomycin and arbekacin, drugs of treatment for MRSA infections].
Kobayashi Y
Nihon Rinsho; 1992 May; 50(5):1054-9. PubMed ID: 1507428
[TBL] [Abstract][Full Text] [Related]
19. Combined therapy with arbekacin and fosfomycin for methicillin-resistant Staphylococcus aureus infections.
Kono K; Takeda S; Tatara I; Arakawa K; Tanaka H; Miyake S; Minamikawa H; Hoshino H; Sato M; Hattori F
Jpn J Antibiot; 1994 Jun; 47(6):798-803. PubMed ID: 8072189
[TBL] [Abstract][Full Text] [Related]
20. Prediction of aminoglycoside response against methicillin-resistant Staphylococcus aureus infection in burn patients by artificial neural network modeling.
Yamamura S; Kawada K; Takehira R; Nishizawa K; Katayama S; Hirano M; Momose Y
Biomed Pharmacother; 2008 Jan; 62(1):53-8. PubMed ID: 18083323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
